REG - Iconic Labs PLC - Restoration of Trading

Iconic LabsAnnouncement

25/01/2023 12:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230125:nRSY8611Na&default-theme=true

RNS Number : 8611N  Iconic Labs PLC  25 January 2023

Iconic Labs PLC

 

("Iconic" or the "Company")

 

Restoration of Trading

 

 

Iconic Labs PLC (LSE:ICON), a multi-divisional new media and technology
business, is pleased to announce that the Financial Conduct Authority has
lifted the suspension of the listing in the Company's ordinary shares and as a
result shareholders can once again trade the Company's shares on the London
Stock Exchange.

 

Using the funds secured through the £ 3 million European High Growth
Opportunities Securitization Fund financing facility, the Company will
continue to fulfill its obligations under the Company Voluntary Agreement and
resume the implementation of its corporate plans.

 

Iconic's CEO, Brad Taylor stated:

 

"Iconic has been successfully restructured, we have financing in place, and
the trading suspension has been lifted. The Company is now working to
formalise terms with the various parties that we have been speaking with over
the last few months, but who understandably would not formalise discussions
until the trading suspension was lifted. I look forward to updating
shareholders as these conversations progress."

 

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic
law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is
disclosed in accordance with the Company's obligations under Article 17 of
MAR.

 

For any further information or enquiries please contact:

 

www.iconiclabs.co.uk (http://www.iconiclabs.co.uk)

ir@iconiclabs.co.uk

Iconic Labs PLC

3 Field Court, WC1R 5EF London

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RENGZGZMZKDGFZM